Avantor Inc (AVTR)
20.80
-0.36
(-1.68%)
USD |
NYSE |
Nov 15, 11:46
Avantor Cash from Operations (Quarterly): 244.80M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 244.80M |
June 30, 2024 | 281.10M |
March 31, 2024 | 141.60M |
December 31, 2023 | 251.60M |
September 30, 2023 | 230.70M |
June 30, 2023 | 168.20M |
March 31, 2023 | 219.50M |
December 31, 2022 | 205.60M |
September 30, 2022 | 258.30M |
June 30, 2022 | 227.50M |
March 31, 2022 | 152.20M |
December 31, 2021 | 301.00M |
September 30, 2021 | 261.90M |
June 30, 2021 | 263.80M |
Date | Value |
---|---|
March 31, 2021 | 126.90M |
December 31, 2020 | 306.00M |
September 30, 2020 | 281.50M |
June 30, 2020 | 89.20M |
March 31, 2020 | 253.10M |
December 31, 2019 | 87.00M |
September 30, 2019 | 197.90M |
June 30, 2019 | -5.90M |
March 31, 2019 | 75.00M |
December 31, 2018 | 69.90M |
September 30, 2018 | 108.20M |
June 30, 2018 | -23.80M |
March 31, 2018 | 46.20M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
87.00M
Minimum
Dec 2019
306.00M
Maximum
Dec 2020
217.58M
Average
237.75M
Median
Cash from Operations (Quarterly) Benchmarks
Revvity Inc | 147.88M |
Bruker Corp | 38.40M |
Azenta Inc | 1.791M |
Harvard Bioscience Inc | -0.842M |
Bionano Genomics Inc | -20.98M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | -40.50M |
Cash from Financing (Quarterly) | -198.60M |
Free Cash Flow | 747.20M |
Free Cash Flow Per Share (Quarterly) | 0.2987 |
Free Cash Flow to Equity (Quarterly) | 397.90M |
Free Cash Flow to Firm (Quarterly) | 241.78M |
Free Cash Flow Yield | 5.27% |